2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
Podden och tillhörande omslagsbild på den här sidan tillhör Biotechnology Innovation Organization. Innehållet i podden är skapat av Biotechnology Innovation Organization och inte av, eller tillsammans med, Poddtoppen.
